[ad_1] The president of South Korean pharmaceutical company, Celtion, “Seo Jung-jin”, said his company will apply for an emergency use permit to treat the emerging coronavirus, which is being developed by the Ministry of Food Safety and drugs next month. The company announced “CT-P59”, which is a monoclonal antibody treatment …
Read More »